Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 2/2010

01-04-2010 | Editorial

Challenges and opportunities of publishing supplements at Arthritis Research & Therapy

Authors: Frances Mulvany, Jo Baker, Peter E Lipsky, Ravinder N Maini

Published in: Arthritis Research & Therapy | Issue 2/2010

Login to get access

Excerpt

Supplements are the cause of much debate in the world of journal publishing. Supplements are criticized for the fact that often they are funded by an external source, and journals have been known to shy away from their publication [1]. But is refusing to publish supplements the only answer? At Arthritis Research & Therapy, we feel that - if subjected to the full rigors of peer review - supplements can provide invaluable educational resources, exploring themes in a detailed and focused way that might not always be possible in the main journal. …
Literature
1.
The perils of journal and supplement publishing. Lancet. 2010, 375: 347-10.1016/S0140-6736(10)60147-X.
2.
3.
4.
5.
Graf C, Battisti WP, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, Field EA, Gurr JA, Marx M, Patel M, Sanes-Miller C, Yarker YE, for the International Society for Medical Publication Professionals: Good publication practice for communication company sponsored medical research: the GPP2 guidelines. BMJ. 2009, 339: b4330-10.1136/bmj.b4330.CrossRefPubMed
6.
Jacobs A, Wager E: European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005, 21: 317-321. 10.1185/030079905X25578.CrossRefPubMed
Metadata
Title
Challenges and opportunities of publishing supplements at Arthritis Research & Therapy
Authors
Frances Mulvany
Jo Baker
Peter E Lipsky
Ravinder N Maini
Publication date
01-04-2010
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2010
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2988

Other articles of this Issue 2/2010

Arthritis Research & Therapy 2/2010 Go to the issue

Research article

B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin

Research article

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus

Research article

Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment

Editorial

Clinical effectiveness of biologics in clinical practice

Research article

Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin

Research article

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits